Articles published by Oncoinvent AS
Oncoinvent to Present at Evercore ISI 2024 Emerging Biotech Conference
February 21, 2024
From Oncoinvent AS
Via Business Wire
Oncoinvent Initiates Radspherin® Phase 2A Trial
August 25, 2022
From Oncoinvent AS
Via Business Wire
Oncoinvent to Participate in Upcoming Virtual Investor Conferences
February 15, 2022
From Oncoinvent AS
Via Business Wire
Oncoinvent appoints Adrian Senderowicz MD to its Board of Directors
February 04, 2022
From Oncoinvent AS
Via Business Wire
Oncoinvent Announces Completion of Enrollment in the RAD-18-002 Phase 1 Clinical Study
November 08, 2021
From Oncoinvent AS
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|